
    
      This will be a phase I protocol of Vincristine, Dexamethasone, Doxorubicin, and
      PEG-asparaginase (VPLD) and metformin conducted in the Sunshine Project sites for children
      with recurrent ALL. All sites will be eligible to open this study, provided they agree to
      adhere to all study procedures and make a good faith effort to obtain all pharmacodynamic and
      pharmacokinetic evaluations requested.
    
  